Report Overview:
The Global Diagnostic Biomarkers Market achieved a valuation of $50.36 Billion in 2022 and is anticipated to exceed $123.84 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 11.9% during the forecast period from 2024 to 2032.
Key Market Players:
Biocrates Life Sciences AG, Augurex Life Sciences Corp., Biomedical Corp., Target Discovery,...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek